1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Akero Therapeutics, Inc.

Akero Therapeutics, Inc.

AKRO
Akero Therapeutics, Inc.US flagNASDAQ Global Select
54.65
USD
- -
- -
4.50BMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
- -
14
46
80
101
115
173
285
+ Selling, General & Admin
- -
2
9
15
19
30
31
38
+ Research & Development
- -
12
37
65
82
85
142
247
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-14
-46
-80
-101
-115
-173
-285
- Non-Operating (Income) Loss
- -
68
-2
-1
- -
-3
-21
-33
+ Interest Expense, Net
- -
- -
- -
- -
- -
-3
-21
-33
+ Interest Expense
- -
- -
- -
- -
- -
1
3
5
- Interest Income
- -
- -
- -
- -
- -
4
24
38
+ Other Non-Op (Income) Loss
- -
68
-2
-1
- -
- -
- -
- -
Pretax Income
- -
-82
-44
-79
-101
-112
-152
-252
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-82
-44
-79
-101
-112
-152
-252
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-82
-44
-79
-101
-112
-152
-252
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-82
-44
-79
-101
-112
-152
-252
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-82
-44
-79
-101
-112
-152
-252
EBIT
- -
-14
-46
-80
-101
-115
-173
-285
EBITDA
- -
-14
-46
-80
-101
-115
-173
-285
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
- -
-14
-46
-80
-101
-115
-173
-285
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
21
15
31
35
39
53
67
Basic EPS, GAAP
- -
-3.85
-2.9
-2.52
-2.89
-2.87
-2.89
-3.75
Basic EPS from Cont Ops
- -
-3.85
-2.9
-2.52
-2.89
-2.87
-2.89
-3.75
Diluted Weighted Avg Shares
- -
21
15
31
35
39
53
67
Diluted EPS, GAAP
- -
-3.85
-2.9
-2.52
-2.89
-2.87
-2.89
-3.75
Diluted EPS from Cont Ops
- -
-3.85
-2.9
-2.52
-2.89
-2.87
-2.89
-3.75

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
1
77
138
271
194
355
560
770
+ Cash, Cash Equivalents & STI
1
76
136
268
188
351
550
743
+ Cash & Cash Equivalents
1
76
65
187
150
250
234
340
+ ST Investments
- -
- -
72
81
38
102
316
403
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
2
3
5
4
10
27
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
2
2
1
20
56
+ Property, Plant & Equip, Net
- -
- -
- -
2
2
1
1
1
+ Property, Plant & Equip
- -
- -
- -
2
2
1
1
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
19
55
+ LT Investments
- -
- -
- -
- -
- -
- -
19
55
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
1
77
138
273
196
357
580
826
+ Payables & Accruals
- -
2
8
12
24
18
17
38
+ Accounts Payable
- -
1
1
3
7
8
7
9
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
7
9
18
10
10
29
+ ST Debt
- -
- -
- -
- -
- -
- -
1
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
1
1
+ Other ST Liabilities
- -
- -
2
- -
1
1
1
1
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
2
- -
1
1
1
1
Total Current Liabilities
- -
2
9
13
25
19
19
40
+ LT Debt
- -
- -
- -
2
1
11
26
36
+ LT Borrowings
- -
- -
- -
- -
- -
10
25
35
+ LT Finance Leases
- -
- -
- -
2
1
1
1
1
+ Other LT Liabilities
5
125
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
5
125
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
5
125
- -
2
1
11
26
36
Total Liabilities
5
127
9
15
26
30
45
76
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
37
259
468
479
749
1,109
1,575
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
37
259
468
479
749
1,109
1,575
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-5
-87
-130
-210
-310
-422
-574
-826
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
1
Equity Before Minority Interest
-5
-50
129
259
169
327
535
750
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-5
-50
129
259
169
327
535
750
Total Liabilities & Equity
1
77
138
273
196
357
580
826
Shares Outstanding
26
26
29
35
35
47
56
72
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
2
2
1
1
1
Net Debt
-1
-76
-65
-187
-150
-240
-209
-305
Net Debt to Equity
13.1
152.2
-50.33
-72.37
-88.99
-73.56
-39.09
-40.65
Tangible Common Equity Ratio
-693.62
-64.7
93.2
94.65
86.48
91.58
92.25
90.83
Current Ratio
2.87
32.93
14.73
20.7
7.7
18.61
29.27
19.38
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
- -
-82
-44
-79
-101
-112
-152
-252
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
76
2
6
11
24
13
19
+ Stock-Based Compensation
- -
- -
2
6
10
23
21
30
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
76
- -
- -
1
1
-8
-11
+ Chg in Non-Cash Work Cap
- -
1
6
2
10
-4
-7
3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-1
-1
-2
2
-7
-17
+ Inc (Dec) in Accts Payable
- -
2
7
4
12
-6
- -
21
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-5
-36
-71
-80
-93
-145
-230
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-5
- -
- -
- -
- -
- -
-1
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
-5
- -
- -
- -
- -
- -
-1
+ Cash (Repurchase) of Equity
- -
- -
95
203
- -
241
335
423
+ Increase in Capital Stock
- -
- -
95
203
- -
241
335
423
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-72
-10
42
-64
-224
-109
+ Dec in LT Investment
- -
- -
- -
105
86
38
210
407
+ Inc in LT Investment
- -
- -
-72
-115
-44
-101
-433
-516
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-5
-72
-10
42
-64
-224
-110
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
10
15
10
+ Cash From Debt
- -
- -
- -
- -
- -
10
15
10
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
85
1
1
1
4
3
13
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
85
96
203
1
256
353
446
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
75
-11
123
-37
99
-16
106
EBITDA
- -
-14
-46
-80
-101
-115
-173
-285
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
- -
-10
-36
-71
-80
-93
-145
-231
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-5
-36
-71
-80
-83
-130
-220
Free Cash Flow per Basic Share
- -
-0.45
-2.36
-2.26
-2.29
-2.37
-2.77
-3.44
Price/Free Cash Flow
- -
- -
-9.39
-11.49
-9.24
-23.09
-8.44
-8.15
Cash Flow to Net Income
- -
0.06
0.81
0.89
0.79
0.83
0.96
0.91
Capital Expenditures
- -
-5
- -
- -
- -
- -
- -
-1